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ABSTRACT 
An Evaluation of the 215GO! Child Obesity Program in the Philadelphia Health Centers 
 
Daniel M. Walker, MPH (Candidate) 
Jessica Robbins, Ph.D. (Preceptor) 
Darryl Brown, Ph.D. (Advisor) 
Objectives: The 215GO! pediatric obesity treatment program operates in 4 of 
Philadelphia’s 8 public neighborhood health centers (HCs).  This program utilizes an 
inter-disciplinary treatment approach where an onsite health educator and nutritionist see 
overweight and obese children and a pediatrician oversees all care.  This study aims to 
examine the impact of the 215GO! pediatric obesity treatment program on both processes 
of care and body-mass-index (BMI) outcomes.   
Methods: A retrospective cohort of overweight and obese patients was formed by a chart 
review of patients from 2 control HCs and 4 HCs offering a 215GO! clinic.  Patient 
charts from July 2007 through June 2008 were reviewed to identify children 3 to 18 years 
old at the time of a pre-selected index visit with BMI > 85th percentile and at least 6 
months of follow-up BMI data.  30 controls were identified from each of 6 health centers 
and 30 215GO! patients were identified from each of the 4 215GO! centers.  In addition 
to index visit and follow-up BMI, patient demographics (age, sex, race/ethnicity) and 
processes of care (whether or not blood pressure was recorded, BMI recorded, BMI 
plotted, diagnosis in the chart, diagnosis in the Management Information System (MIS), 
and whether or not lab tests were taken) were extracted from the chart. 
Results: A total of 296 patients meeting the study criteria were identified.  Multivariate 
analysis using a generalized estimating equation model showed no difference in BMI 
percentile change between 215GO! and control patients (β=-.35 + .22, p=.11).  215GO! 
patients were significantly more likely to have their BMI recorded (OR: 3.69, 95%: 1.61-
8.46), BMI plotted (OR: 2.09, 95%: 1.26-3.47), diagnosis in their chart (OR: 2.01, 95%: 
1.14-3.55), diagnosis in the MIS (OR: 14.31, 95%: 2.61-78.27), and have lipid (OR: 4.75, 
95%: 2.04-11.06), liver (OR: 3.21, 95%: 1.01-10.19), and glucose (OR: 4.75, 95%: 1.85-
12.21) labs taken.   
Conclusion:  The 215GO! program does not improve BMI outcomes for overweight and 
obese children.  However, the program is effective in improving the processes of care for 
those children.  Treatment and counseling methods should be reevaluated to translate 
these improvements in processes of care into improvements in outcomes.   
	  	  	  	  	   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
Introduction 
 The 215GO! pediatric obesity treatment program offered in the Philadelphia 
Health Centers (HCs) is designed to combat the growing prevalence of childhood obesity 
in the city.  The program utilizes a multi-disciplinary team consisting of a pediatrician, a 
health counselor, and a nutritionist to advise and treat overweight and obese patients1.  A 
primary goal of the 215GO! program is to establish a primary care based counseling 
program that effectively treats and manages childhood overweight and obesity.  The 
proposed study aims to evaluate that program in achieving the goal of improved care of 
overweight and obese children.  This report begins with a review of the negative 
economic and health related consequences of childhood overweight and obesity.  Next a 
discussion of the challenges to identifying and treating that condition precedes a brief 
overview of some failed and successful treatment programs.  This discussion will also 
include relevant information about current pediatric guidelines for identifying and 
treating childhood obesity. Finally, a description of the 215GO! program and past efforts 
to evaluate its performance will set the stage for the presently reported research project 
and its results.  A discussion of these results and their policy implications will conclude 
this analysis.   
 
                                                
1	  For	  the	  purposes	  of	  this	  review,	  definitions	  of	  overweight	  and	  obesity	  are	  adopted	  from	  the	  2007	  Expert	  Committee	  Recommendations	  developed	  by	  the	  American	  Academy	  of	  Pediatrics.	  	  ‘Overweight’	  refers	  to	  BMI	  85th-­‐94th	  percentile	  and	  replaces	  the	  term	  ‘At	  Risk	  of	  Overweight’	  developed	  in	  the	  1998	  Expert	  Committee	  Recommendations.	  	  ‘Obese’	  refers	  to	  BMI	  >	  95th	  percentile	  and	  replaces	  the	  term	  ‘Overweight’	  developed	  in	  the	  1998	  Expert	  Committee	  Recommendations.	  	  For	  a	  complete	  discussion	  of	  these	  cut-­‐points	  and	  terminology,	  please	  see	  Barlow	  et	  al.,	  (2007).	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Background 
Economic and Health Consequences of Childhood Overweight and Obesity 
 Childhood overweight and obesity has reached epidemic proportions both in the 
United States and globally.  Recent estimates from the National Health and Nutrition 
Evaluation Survey (NHANES) show the prevalence of overweight and obesity in the 
United States for children ages 2-19 years old from the years 2007-2008 to be around 
31% [1].   A disproportionately large portion of overweight and obese children are from 
minority populations of low socio-economic status [2, 3].  Hampl et al. (2007) show that 
overweight and obese children utilize significantly greater healthcare resources such as 
laboratory services then healthy weight children [2].  Additionally, that study suggests 
that the heavier weight children may also visit the emergency department and their 
primary care physician more often than healthy weight children, but small sample size 
limits this result from being significant [2].  In a study evaluating the cost of health care 
services by children’s body-mass index (BMI) status, Transande et al. (2009) show that 
overweight and obese children ages 6 – 19 years old incur significantly greater annual 
expenditures for outpatient visits, prescription drugs, and emergency room visits [4].  
That study did not take into account indirect costs associated with childhood overweight 
and obesity such as missed school days.  Other studies have shown that childhood 
overweight and obesity leads to decreased earning potential and educational attainment, 
indicating long-term personal and societal economic consequences associated with the 
pediatric condition [5].  Trasande et al. (2009) extrapolate the elevated cost data for all 
the overweight and obese children in the U.S. and estimate that an additional $14.1 
billion is spent annually on outpatient visits, prescription drugs, and emergency room 
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visits by that group [4].  The disproportionate number of overweight and obese children 
that are on Medicaid or SCHIP underscores the economic cost to the nation of childhood 
overweight and obesity [2].   
 The economic cost of the obesity epidemic provides some quantification of the 
underlying co-morbidities associated with the condition.  Short-term co-morbidities 
associated with overweight and obesity include hyperlipidaemia, hypertension, insulin 
resistance, abnormal glucose tolerance, sleep apnea, and orthopaedic complications [6].  
In addition to the above listed physical consequences of childhood obesity, large children 
experience systematic discrimination that leads to low-self esteem, eating disorders, and 
other mental health conditions [6].  Reilly and Kelly (2010) demonstrate the long-term 
consequences of childhood overweight and obesity in a recent systematic review [7].  
Their review highlights that overweight and obese children experience significantly 
increased risk in their adult life of premature death, diabetes, hypertension, ischemic 
heart disease, stroke, asthma, polycystic ovary syndrome, and likelihood to be on 
disability pension [7].  Again, overweight and obese adults experience increased 
healthcare spending relative to healthy weight adults as a result of their weight status [8].  
These economic and health consequences of childhood overweight and obesity combined 
with the high prevalence of the condition indicate the necessity for adequate diagnosis 
and treatment.   
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Identification and Treatment of Childhood Obesity 
 Treatment of childhood overweight and obesity begins with the identification and 
diagnosis of that condition[9].  A recent publication of the recommendations of an expert 
committee developed by the American Academy of Pediatrics provides guidelines for 
best practices for the identification and treatment of childhood overweight and obesity.  
Their guidelines are based on the chronic care model of treatment.  The chronic care 
model frames overweight and obesity within the larger ecological environment 
containing family, community, schools, and policy interactions (Figure 1)[9, 10].  
Overweight and obesity management must consider this complex etiology and utilize 
multi-disciplinary and comprehensive care to prevent and treat the condition.   
 
Figure 1: The chronic care model displaying the complex etiology of overweight and 
obesity and the multi-disciplinary comprehensive treatment program required to treat the 
condition[10].  
The expert committee recommends that a child’s body-mass-index (BMI) is the 
best measure of body fat and the recording and plotting of this measure is the best 
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approach to identifying and treating overweight and obesity [11] (see August, 2008 for a 
discussion of the pros and cons of this measure).  BMI is a low cost and quick measure 
that has been shown to predict body fat accurately in both children and adults [11].  It 
should be noted that for children, the distribution of BMI changes with age similar to how 
height and weight distributions change with age.  Therefore, BMI evaluation in children 
must utilize age and gender specific percentiles to define under, healthy, and overweight 
conditions [11].  Furthermore, that expert panel suggests standard BMI cut points to 
uniformly assess weight status.  The expert panel recommends that BMI be recorded and 
gender and age specific BMI percentile plotted for all well child visits [11].  Additional 
recommendations by that committee and reiterated by a panel of endocrine experts 
include lipid panel testing for all children with BMI 85th to 94th percentile, with fasting 
glucose, alanine aminotransferase (ALT), and aspartate aminotransferase (AST)2 
measured every 2 years for children above 10 years old that posses risk factors for 
abnormal cholesterol levels and type 2 diabetes mellitus [12, 13].  Children with BMI > 
95th percentile should have fasting glucose, ALT, and AST levels measured every 2 years 
regardless of the presence of risk factors identified by a lipid panel [12].  Finally, a 
child’s family history and behavioral attributes should be considered when evaluating the 
risk of overweight and obesity and complications of those conditions.   The committees  
recommend that the BMI, lab, and family history information be utilized to develop a 
treatment plan for obesity.  This treatment regiment should be steadily increased from 
prevention to dietary and behavioral counseling to pharmaceutical intervention over time, 
                                                
2	  ALT	  and	  AST	  are	  products	  of	  liver	  metabolism	  and	  are	  indicators	  of	  both	  insulin	  sensitivity	  and	  non-­‐alcoholic	  fatty	  liver	  disease.	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particularly if children fail show a decrease in their BMI after 3 to 6 months of treatment 
[11, 12].     
Evidence from two studies suggests that pediatric care centers currently fail to 
achieve even modest success in meeting several of the recommendations put forth by the 
expert committees.  Three studies evaluate the performance of pediatricians in identifying 
and managing overweight and obesity.  O’Brien et al. (2004) reviewed charts of children 
age 3 months to 16 years in an urban academic tertiary care hospital that primarily serves 
minority populations [14].  That study revealed a prevalence of obesity of 9.7%, yet in 
only 53% of those cases were children diagnosed as obese [14].  Of obese patients, only 
13% had labs ordered and only 22% were referred to a dietitian [14].  Dorsey et al. 
(2005) conducted a study of 600 children ages 6 to 11 from 2 community based and 2 
academic hospitals in New Haven, Connecticut and showed that despite a prevalence of 
overweight and obesity of nearly 40%, BMI was recorded in only 0.5% of charts [15].  
Additionally, in that study only 20% of overweight patients were diagnosed as 
overweight and only 17% were being treated for that condition [15]. This result is 
reiterated in another study by Hillman et al. (2009) that reviewed 397 medical charts in 
an academic urban pediatric clinic and found a prevalence of overweight or obesity of 
over 40%, yet only 4.3% of patient charts contained a BMI plotted for age and gender 
[16].  That study further revealed that no overweight patients were referred for 
management of care, only 2.9% were recommended to follow-up with their physician, 
and blood work was not ordered on any overweight patients [16]. Furthermore, only 7.4% 
of obese patients were referred for management of care, only 18% were recommended to 
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follow-up with their physician, and blood work was ordered in only 5.3% of obese 
patients [16].   
Several studies attempt to explain the failure of primary care physicians in 
identifying and treating childhood overweight and obesity.   One commonly identified 
reason for this shortcoming is that physicians report low self-efficacy in treating 
overweight and obesity as a result of the many environmental causes of the condition [17-
19].  Additional explanations include lack of onsite support staff such as a dietitian and 
low-reimbursement [19].  Evidence suggests that proximity to a dietitian or nutritional 
counselor significantly effects physician rates of referral to those services and poor 
design of combination of health care services could account for some of the lack of 
physician referrals [20].  Residency training programs also lack established curricula that 
instruct how to diagnose and treat overweight and obesity [21].  A survey of 299 
residency program directors from pediatric, internal medicine-pediatrics, and family 
medicine residency program in 2007 and 2008 found that only 18% of programs offered a 
complete childhood obesity curriculum with training in all of prevention, diagnosis, 
diagnosis of complications, and treatment [21].  Goff et al. (2006) conducted a qualitative 
study that examined the barriers residency programs face in establishing training 
programs for childhood overweight and obesity, despite recognition of this issue as a 
significant problem [17].  Identified barriers include low level of efficacy in treatment, 
lack of a proven treatment strategy, high frustration in treating a disease with a complex 
biological and social etiology, and low economic incentives [17].   
Few efforts to improve physician’s ability to diagnose and treat pediatric 
overweight and obesity have been conducted.  Young et al. (2010) established a learning 
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collaborative (LC) by connecting a total of 20 practice teams (including a physician, a 
nurse, and an administrator) to each other and by hosting two half-day workshops led by 
dietitians, psychiatrists, and other experts in childhood obesity management for each 
practice team [22].  The LC also consisted of several onsite visits by specialists as well as 
monthly conference calls with all the practice teams and lasted a total of 9 months [22].  
Chart audits prior to the LC revealed that BMI was recorded in only 55% of charts, but an 
audit during the last month of the LC showed that BMI was recorded and plotted on an 
age and gender specific curve in 97% of charts [22].  Other results include increased 
preventative measures such as monitoring screen time and giving preventative advice 
during routine visits [22].  This program provides an example of an effective training 
regiment to increase the rate of BMI recording and thereby the diagnosis of overweight 
and obesity.   
Additional evidence of clinic based programs that both identify and successfully 
treat pediatric obesity is slim [23].  McCallum et al. (2007) and Wake et al. (2009) report 
a lack of improved BMI after 12 months in a clinic based randomized intervention in 
primary care practices Melbourne, Australia [24, 25].  Those two studies resulted from 
the Live, Eat and Play (LEAP) program that involved an initial visit followed by 4 
consultations with a pediatrician over 12 weeks [24, 25].  The consultations included a 
parent and focused on nutrition, physical activity, and sedentary behavior.  Alternatively, 
a recent report of preliminary findings from the Healthy Weight Clinics established in 8 
community health centers throughout Massachusetts suggest promising results from this 
interventional model [26].  Patients are referred to the clinic by their pediatrician and are 
then consulted by a dietitian, monitored by a clinician, and followed-up with by a case 
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manager.  Families are involved and the program aims to improve nutrition, increase 
physical activity, and decrease sedentary activity.  Children visit the clinic every one to 
two months for a total of six visits before they graduate the program.  Preliminary 
analysis of results from this program reveal that 50% of patients visiting the clinic at least 
twice reduced their BMI [26].  Program directors cite the continuity of care delivered as 
well as the integration of care with health information technology as aspects of the 
program that account for its success.  This evidence provides promising results from a 
clinic based overweight and obesity treatment program, yet more time will yield more 
information as to the success of the program and factors that influence that success.   
A recent systematic review of randomized controlled trial interventional programs 
describes that combined physical activity with dietary and behavioral counseling is most 
effective at achieving decreased BMI [27].   That systematic review was not limited to 
clinic based interventions and included community and school based interventions in 
addition to clinic-based interventions.  The review also points out the lack of limited 
quality data as well as a consensus on effective treatment programs.  Additionally, that 
systematic review highlights that intervention effectiveness varies depending on age due 
to changing metabolism, nutritional need, physical and psycho-social maturation 
throughout childhood [27].  Evaluation of programs aimed at improving diagnosis as well 
as treatment of childhood overweight and obesity remains a critical issue for primary care 
providers that seek to address this epidemic.   
 
215GO! 
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 This literature review has thus far focused on the consequences of childhood 
obesity and challenges to identifying and treating the condition.  The 215GO! program 
was developed in light of these issues concerning childhood overweight and obesity and 
represents an inter-disciplinary approach to treating the disease. The program alters the 
organizational environment of the Health Center by providing comprehensive disease 
management between a physician, a nutritionist, and a health educator.  According to 
Donabedian’s framework for the assessment of the quality of care, this interventional 
program presents a structural element [28].  The novel structural element should lead to 
an improvement in the processes of care for the overweight and obese children it is 
designed to help.  Likewise, the improvements in processes of care should lead to better 
outcomes for those children (Figure 2).  This evaluation of the 215GO! program is guided 
by this theoretical framework.   
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Figure 1:  Some hypothetical relationships between characteristics of the Donabedian 
structure, process, and outcome framework.  Adapted from Donabedian, A., 2002. [29]. 
 
The 215GO! program began in 2004 and now operates within four of the 
Philadelphia Department of Public Health (PDPH) health centers (#2, #5, #6, #9).  The  
health centers (HCs) provide care without regard to insurance status or ability to pay to a 
predominately minority population.  A recent estimate suggests a prevalence rate of 
overweight and obesity of 34% for children that attend the health centers [30]. 215GO! 
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provides counseling with a nutritionist and a health educator for overweight or obese 
children that are patients within the health center and are referred by their pediatrician.  
215GO! is an acronym: 2-limit screen time to less than two hours a day; 1- minimum of 
one hour per day of physical activity; 5- five servings of fruit and vegetables per day; G – 
Great; O- Opportunities.  The utilization of a health educator and nutritionist in addition 
to a pediatrician gives the program a multi-disciplinary approach to treatment of pediatric 
obesity.  The program seeks to fulfill five primary goals: 
1) To provide comprehensive care for overweight children and adolescents and those 
at risk for overweight who seek care 
2) To prevent and reduce obesity-related complications such as metabolic syndrome, 
diabetes mellitus, dyslipidemia, hypertension, sleep apnea syndrome, polycystic 
ovary syndrome, and other related conditions 
3) To attach patients previously without a medical home to primary care 
4) To improve self-esteem and increase positive life-style changes among these 
patients through behavior modification counseling and education and nutrition 
assessment and counseling 
5) To collect and analyze data to assess the effect of the project 
The 215GO! program is funded by a combination of sources, including city and state 
funds, and funding from the Department of Health and Human Services Maternal and 
Child Health Bureau.  Additionally, the fact that Pennsylvania state Medicaid covers 
nutritional consultation allows some of the costs of the program to be absorbed by that 
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welfare program [31].  However, the fifth goal of 215GO!, to collect and analyze data to 
assess the effect of the project, is critical to maintaining and increasing funding for the 
project.  Assessment of the program can assist in scaling up the project to more health 
centers in the city.   
Past efforts to determine the effectiveness of the 215GO! program in treating 
overweight and obesity have focused on decreased BMI as a primary outcome [32, 33].  
Berhane (2009) used data from 215GO! patients at two HCs (#5, #6) to examine whether 
individuals that attend the 215GO! program multiple times had better BMI outcomes than 
those that attended the clinic only once [32]. That study found that those who attended 
215GO! multiple times had a significantly greater portion of patients that improved or 
maintained their weight status then those that only attended once [32].  Jeffrey (2010) 
compared BMI outcome of 215GO! patients in two HCs (#5 and #9) to a control group of 
non-215GO! patients at both 215GO! and non-215GO! clinics (#3 and Strawberry 
Mansion) [33].  That study produced inconclusive results as to the benefits of the 
program [33].    
This project described here adds to those studies by not only expanding the number of 
health centers and patients included in the analysis, but also by including variables that 
seek to measure overall identification and management of overweight and obesity as 
outlined by the expert committee recommendations discussed above.  Evaluation of the 
215GO! program on its effect on the identification and general management of care for 
overweight and obese patients has not previously been conducted.  Also, the lack of 
literature describing successful approaches to improving the management of childhood 
overweight and obesity calls for more research that addresses this issue.  The 215GO! 
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program provides a unique opportunity to assess a program that aims to improve care of 
that condition.  Assessment of not only beneficial BMI outcomes but improved 
management of care due to the 215GO! program will contribute to the current challenge 
physicians face in identifying and treating pediatric overweight and obesity.  Adding to 
this body of knowledge of how to better identify and treat childhood overweight and 
obesity can help other clinicians develop programs to improve their care and benefit their 
patients.   
 
 
Specific Aims 
 
This project specifically aims to address the question of whether patients at health centers 
with a 215GO! program show improved outcomes and processes of care over patients 
that either do not utilize this service or attend a health center that does not offer that 
service.   
(1) Do obese and overweight pediatric patients at health centers with a 215GO! 
program have more favorable changes in BMI percentile over 6-24 months of 
follow up than either children that attend the same health center but do not utilize 
215GO! services or children that attend health centers without a 215GO! clinic? 
(2) Are obese and overweight pediatric patients at health centers with a 215GO! 
program more likely to have their laboratory tests (lipids, liver enzymes, or 
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glucose) taken than either children that attend the same health center but do not 
utilize 215GO! services or children that attend health centers without a 215GO! 
clinic? 
(3) Are obese and overweight pediatric patients at health centers with a 215GO! 
program more likely to have their blood pressure or BMI recorded, or BMI 
plotted than either children that attend the same health center but do not utilize 
215GO! services or children that attend health centers without a 215GO! clinic? 
(4) Are obese and overweight pediatric patients at health centers with a 215GO! 
program more likely to be diagnosed in both the chart and the Management 
Information System (MIS) as obese or overweight than either children that attend 
the same health center but do not utilize 215GO! services or children that attend 
health centers without a 215GO! clinic? 
 
 
 
 
Research Design and Methods 
Study Design and Setting 
A retrospective cohort study was conducted by reviewing medical charts at 6 of 
the Philadelphia Health Centers (HCs): #2, #3, #5, #6, #8, #9.  Four of these HCs (2, 5, 6, 
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9) offer the 215GO! pediatric obesity treatment program.  The 2 control Health Centers 
do not offer any specialized overweight or obesity management programs.   
 
Subjects 
Pediatric patients aged 3 to 18 who had a well child visit at any of the 6 HCs 
between July 1, 2007 and June 30, 2008, a BMI > 85th percentile, and a follow-up visit at 
least 6 months after the initial visit with a recorded height and weight were eligible for 
this study.  Pregnant girls were excluded from the study. Patient medical record numbers 
(MRNs) were randomized and an initial visit index date was pre-selected from the PDPH 
Management Information System (MIS).  Patient charts were screened to determine BMI 
percentile at the index visit and possession of adequate follow-up data.  BMI was 
calculated as weight in kilograms divided by height in meters squared.  This BMI value 
corresponds to a z-score based on the normal distribution of BMI values for that specific 
age and gender.  The z-score translates into a BMI percentile. Patients with a BMI > 95% 
at the index visit were categorized as obese, and patient with BMI > 85% but <95% were 
categorized as overweight as per the AAP guidelines [11].  The first 30 eligible patient 
charts identified from each of the HCs from the 3 patients groups underwent further 
review to extract demographic, clinical, and quality of care data. Specific patient groups 
were (1) patients using the 215GO! clinics; (2) overweight or obese patients at HCs in 
which the 215GO! clinics operate (HCs #2, #5, #6 and #9) but have never utilized the 
215GO! services; (3) overweight or obese patients at HCs without 215GO! clinics (HC 
#3 and #8).  Control patients were defined as having never been seen by 215GO! staff.  
215GO! patients were defined as having at least 1 visit with a 215GO! health educator or 
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nutritionist.   
 
Outcomes 
  Processes of care indicators included recording of blood pressure (BP), BMI, BMI 
plot, diagnosis in the chart at the date of the index visit, and diagnosis in the MIS at the 
date of the index visit. BP was recorded as taken if the value was noted in the chart. BMI 
recording was counted if either BMI value or BMI percentile was noted.  BMI plot was 
counted as whether the child’s BMI was plotted on either a CDC or PDPH gender 
specific BMI graph for the child’s age at the index visit.  Diagnosis was counted as 
having been recorded if any diagnosis of ‘overweight’ or ‘obese’ was listed in the chart.    
MIS coding of overweight or obese was determined according to ICD-9 codes (278.0-
278.8) and was counted if an overweight or obese code was entered into the MIS for that 
visit date [34].   
 Laboratory test results included lipid profile, liver enzymes, and glucose test.  
Lipid profile was defined as at least including values for both low-density lipoprotein 
(LDL) and high-density lipoprotein (HDL), or as total cholesterol alone.  Liver enzyme 
test was defined as including values for both AST and ALT.  Glucose test was required to 
have been determined from blood, but included both random or fasting glucose tests.  Lab 
tests were counted as conducted if they occurred within a year pre- or 90 days post- the 
index visit.   
 
Analysis 
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 All analyses were conducted using SAS 9.1.3.  BMI change was analyzed using a 
transformation to normalize this dependent variable and was calculated by adding a 
constant to the difference between the index visit and follow-up visit BMI percentile to 
make all change values positive.  The change values were then log normalized.  A 
reduction in age and gender specific BMI percentile is therefore represented as a positive 
coefficient value. Individuals with data entry error for either index or follow-up visit 
height or weight were excluded from this analysis.  A generalized estimating equation 
(GEE) regression model was used to evaluate change in BMI percentile because this 
model provides estimates that are robust to the correlation effect present in multilevel 
settings that involve subject clustering (i.e. Health Center). The GEE model was fit on the 
transformed BMI percentile change that included 215GO, HC as a 215GO! center, sex 
(male), age in years, BMI category (obese), follow-up time, and race variables of White/ 
Other, Asian, and Hispanic with Blacks as the reference group. Interaction terms between 
215GO! group status and age as well as 215GO! group status and BMI category were 
also included in the model.  Interaction terms were assessed by comparing adjusted-R2 
values in linear regression models and the model with the greatest adjusted-R2 was used.  
 The effect of the number of 215GO! visits on the BMI percentile change also 
utilized the transformed BMI percentile change described above as the dependent 
variable.  The number of 215GO! visits in between the index visit and the follow-up visit, 
but not counting either of those visits, was determined from the chart review.  Categories 
of visits were 0 visits, 1 visit, and 2 or more visits.  A GEE model was fit for transformed 
BMI percentile change controlling for HC as a cluster effect and including the visit 
categories, sex (male), age in years, BMI category (obese), and follow-up time.   
 19 
Crude odds ratios (ORs) for processes of care indicators BP, BMI recorded, BMI 
plotted, diagnosis, and MIS coded were analyzed using naive logistic regression.  A 
multivariate GEE model with HC as a cluster effect was used to determine adjusted ORs 
for those measures.  Adjusted models for quality of care measures included the covariates 
215GO!, HC as a 215GO! center, sex (male), age in years, BMI category (obese), and 
race variables of White/ Other, Asian, and Hispanic with Blacks as the reference group.   
Interaction terms between 215GO! group status and all other independent variables were 
assessed by comparing AIC values from multivariate logistic regression models.  No 
interaction terms were included in the final model.  Crude ORs for lab tests were 
calculated using naive logistic regression.  Adjusted ORs for lab tests were calculated 
using multivariate logistic regression models that included 215GO!, HC as a 215GO! 
center, sex (male), age in years, and BMI category (obese).   
  
Human Subjects Consideration 
 This study was approved by the Philadelphia Department of Public Health 
Institutional Review Board as well as the Health Commissioner’s Office.  Parental 
informed consent and HIPAA approval were waived for this study.   
 
Results 
 Characteristics of the study population are reported in Table 1 along with a χ2 p-
value for difference between the distribution of a given characteristic in the controls and 
215GO! groups.  A total of 296 patients were identified as eligible for this study based on 
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the criterion outlined above. Of the 296 total patients, 179 (60%) were control patients 
and 117 (40%) were 215GO! patients.  136 (46%) of all patients were male and 160 
(54%) were female and there was no significant difference in the gender distribution 
between the control and 215GO! group (p=.2).  The majority of all patients were black 
(66%), and a significantly greater portion of the control than the 215GO! group was black 
(p=.009).  Mean age at the initial visits for controls was 10.5 years + 4.6 years and for the 
215GO! group was 11.7 years + 3.9 years, and this difference is statistically significant 
(p=.0183).  Mean follow-up time for the controls was 1.06 years + .3 years and 1.07 years 
+ for the 215GO! group and this difference is not significant (p=.7).  A significantly 
greater portion (p<.0001) of the 215GO! subjects (82.9%) were obese then the controls 
(47%).   
 Overall, 63% of the entire study population was found to decrease their BMI 
percentile, with 56% of 215GO! patients experiencing a reduction in BMI percentile and 
66% of control patients decreasing their BMI percentile.  Comparison between the two 
groups utilized a GEE model with transformed BMI percentile change as the outcome 
and is presented in Table 2.  Three patients were excluded from this analysis due to data 
entry error.  The transformation of the variable allows only the direction and significance 
of explanatory variables to be interpreted, but not the magnitude.  Health Center is 
included in the model as a cluster effect to control for correlation among individuals seen 
at the same health center. Independent variables included in the model were 215GO!, HC 
as a 215GO! center (HCs 2,5,6,9), sex (male), age in years, BMI category (obese), 
follow-up time in months, and race variables White/Other, Asian, and Hispanic with 
Black as the reference group.  Interaction terms between 215GO! group status and age as 
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well as 215GO! group status and BMI category were also included in the final model.  
Coefficients from this model show that patients in 215GO! had no difference in BMI 
percentile change compared to control patients (β= -.35 + .22, p=.1).  Controls at HCs 
containing a 215GO! program increased their BMI percentile (β= -.05 + .01, p<.0001) 
compared to controls at non-215GO! HCs.  There was no difference in BMI percentile 
change between males and females (β= -.006 + .04, p=.87) or between obese and 
overweight patients (β=.13 + .12, p=.26).  Older patients significantly increased their 
BMI percentile compared to younger patients (β= -.03 + .01, p=.01).  Patients with longer 
follow-up time decreased their BMI more than those with shorter follow-up time (β=.01 
+ .005, p=.02).  White and Other (β= .11 + .07, p=.14) and Hispanics (β= -.03 + .03, 
p=.4) had no difference in BMI percentile change compared to Blacks, but Asians (β= -
.06 + .023, p=.007) significantly increased their BMI percentile compared to Blacks.  The 
interaction effect between patient 215GO! status and age shows that older 215GO! 
patients decreased their BMI compared to younger 215GO! and all non-215GO! patients 
(β=.03 + .01, p=.006).  The interaction between patient 215GO! status and BMI category 
improved the model fit but there was no difference between obese 215GO! patients and 
non-obese 215GO! patients as well as all controls (β=-.2 + .19, p=.3). 
 Results of GEE analysis examining the impact of the number of 215GO! visits 
between the index and follow up visit on BMI percentile change for that group are 
presented in Table 3.  Similar to the BMI percentile change results for the entire study 
population, the transformation of the variable allows only the direction and significance 
of explanatory variables to be directly interpreted, but not the magnitude.  Health Center 
and race are both included as cluster effects in the GEE model to control for the 
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correlation among individuals in either the same HC or the same race.  Model inputs 
include visit categories 1 and  >2 with 0 visits as the reference group, sex (male), age in 
years, BMI category (obese), follow-up time in months.  No differences in BMI change 
are observed between patients with either 1 (β= .015 + .03, p=.463) or > 2 (β= .031 + .06, 
p=.63) visits to those with 0 visits.  Similar to the GEE analysis for the entire study 
population, 215GO! patients showed no difference in BMI percentile change between 
male and female (β=.003  + .012, p=.85) or between obese and overweight (β=.-.09 + .06, 
p=.17).  Also similar to the entire study population, each additional month of follow-up 
time was associated with a significant decrease in BMI percentile (β=.01 + .002, 
p<.0001).  For 215GO! patients, each additional year of age was associated with a 
significant decrease in BMI percentile (β=.008 + .003, p=.004).   
 Analysis of processes of care indicators BP, BMI recorded, BMI plotted, 
diagnosis in the chart, and MIS coded overweight or obesity, are presented in Table 4.  
MIS codes were only retrieved for 185 (62%) patients due to clerical procedures at the 
PDPH. Crude ORs were calculated using a naive logistic regression model containing 
only the independent variable of interest. Multivariate analysis utilized GEE models 
using HC as a cluster effect to calculate adjusted ORs.  Variables included in GEE model 
were 215GO!, HC as a 215GO! center (HCs 2,5,6,9), sex (male), age in years, BMI 
category (obese), follow-up time in months, and race variables White/ Other, Asian, and 
Hispanic with Black as the reference group.  No interactions of independent variables 
with 215GO! group status were found to significantly improve models based on 
comparison of AIC values from multivariable logistic regression models. Adjusted ORs 
show that 215GO patients are more likely to have their BMI recorded (OR: 3.69, 95%: 
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1.61-8.46) and plotted (OR: 2.09, 95%: 1.26-3.47), a diagnosis in their chart (OR: 2.01, 
95%: 1.14-3.55), and an MIS code (OR: 14.31, 95%: 2.61-78.27) entered than non-
215GO! patients, but no more likely to have their BP recorded (OR: .79, 95%: .56-1.12) 
as the non-215GO! patients.    The HC containing a 215GO! program had no significant 
effect on any of the quality of care indicators (see Table 4).  Males had a significantly 
lower likelihood of having their BMI recorded than females (OR: .48, 95%: .34-.69).  
Older patients were more likely to have their BP recorded (OR: 1.09, 95% CI: 1.03-1.17), 
a diagnosis in their chart (OR: 1.18, 95%: 1.09-1.28), and an MIS code for overweight or 
obesity (OR: 1.23, 95% 1.09-1.38).  Obese patients were not significantly more likely to 
have their BP taken (OR: .72, 95%: .39-1.29) or their BMI recorded (OR: 1.25, 95%: .81-
1.96) or plotted (OR: .83, 95%: .68-1.02) than overweight patients, but they were 
significantly more likely to have a diagnosis in their chart (OR: 4.39, 95%: 2.16-8.92) or 
a MIS code (OR: 5.4, 95%: 1.7-17.17).    
 Results of analyses of laboratory testing rates are presented in Table 5.  All lab 
tests were counted as having occurred if conducted within a year pre- or 90 days post- 
index visit.  Crude ORs were calculated using a simple logistic regression model 
containing only the independent variable of interest.   Covariates of 215GO, HC as a 
2125GO center, sex (male), age in years, and BMI category (obese) were imputed into a 
multi-variate logistic regression model to determine adjusted ORs.  The low number of 
positive lab results prevents the use of a GEE model that would control for the cluster 
effect of each HC.  However, controlling for the included covariates, the 215GO! patients 
were more likely than control patients to have their lipid profile (OR: 4.75, 95% 2.04 -
11.06), liver enzymes (OR: 3.21, 95% 1.01-10.19), and glucose score (OR: 4.75, 95% 
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1.85-12.21) evaluated.  Control patients at 215GO! centers were no more likely to have 
their labs taken than control patients at non-215GO! centers (see Table 5).  None of the 
other covariates (sex, age, BMI category) significantly increased the chance of any of the 
labs being taken.   
 
Table 1: Characteristics of Study Population 
 Control Group 
(n=179) 
 215GO 
Group (n=117) 
 p-value 
Gender (%)     0.21 
              Male 77    (57%)  59   (50.4%)   
              Female 102  (43%)  58   (49.6%)   
      
Health Center (%)      
                2 30   (16.7%)  30   (25.6%)  0.06 
                3 30   (16.7%)  -  - 
                5 29   (16.2%)  30   (25.6%)  0.05* 
                6 31   (17.3%)  30   (25.6%)  0.08 
                8 30   (16.7%)  -  - 
                9 29   (16.2%)  27   (23%)  0.14 
      
Race  (%)      
               Black 129 (75.4%)  67   (57.7%)  0.009* 
               Asian 7     (4.1%)  13   (11.2%)  0.02* 
               Hispanic 26   (15.2%)  32   (27.6%)  0.01* 
               White/ Other 9     (5.25%)  4     (3.4%)  0.51 
      
      
Mean IV Age (SD) 10.5 yrs (4.6)  11.7 yrs (3.9)  0.02* 
Mean Follow-Up Time 
(SD) 
1.06 yrs (.3)  1.07 yrs (.28)  0.68 
      
BMI Category (%)     <.0001* 
              Overweight  95   (53%)    20   (17.1%)   
              Obese 84   (47%)  97   (82.9%)   
      
215GO! Visits      
              0   visits  -  54   (46.1%)   
              1   visit  -  32   (27.4%)   
           > 2   visits  -  31   (26.5%)   
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Table 2: GEE model for transformed BMI decrease for total study population 
 Coeff (SE) Z-score P-Value 
215GO  -0.3546   (0.222)  -1.60 0.11 
HC 215GO -0.0562   (0.012) -4.80 <.0001* 
Sex (male)  -0.0062    (0.038)  0.16 0.87 
Age (yrs) -0.0267    (0.011) -2.46 0.01* 
BMI Category (obese)  0.1323     (0.118)  1.12 0.26 
Follow-Up Time (mnths)  0.0128   (0.005)  2.36 0.02* 
White/ Other  0.1136    (0.076)  1.48 0.14 
Asian -0.0626     (0.023)  -2.69 0.007* 
Hispanic -0.0275   (0.031) -0.89 0.37 
215GO * Age   0.0343   (0.012)  2.77 0.006* 
215GO * BMI Category -0.2016   (0.188) -1.07 0.28 
Note: Model includes HC as cluster effect. 
 
Table 3:  GEE model for transformed BMI decrease of 215GO patients 
 Coeff (SE) Z-score P-Value 
1 Visit 0.0172   (0.032) 0.54 0.59 
>2 Visits 0.0251   (0.062) 0.40 0.69 
Sex (male) 0.0027   (0.018) 0.15 0.88 
Age (yrs) 0.0080   (0.003) 2.78 0.005* 
BMI Category (obese) -0.0897  (0.065) -1.38 0.17 
Follow-Up Time (mnths) 0.0108   (0.002) 4.46 <.0001* 
Note:  Model includes HC as cluster effect. 
 
 
 
	  	  	  	  	   
Table 4: Assessment of processes of care indicators. 
 Outcome     
 BP Recorded BMI Recorded BMI Plotted Dx in Chart MIS Coded 
 Controls= 168 (94%) 
215GO = 104 (89%) 
Controls= 96 (54%)  
215GO = 94 (80%) 
Controls= 60 (34%)  
215GO = 53 (46%) 
Controls= 93 (52%)  
215GO = 94 (80%) 
Controls= 41 (34%) 
215GO= 56 (88%) 
 Crude 
OR 
(95% 
CI) 
Adjusted 
OR (95% 
CI) 
Crude 
OR 
(95% 
CI) 
Adjusted 
OR (95% 
CI) 
Crude 
OR (95% 
CI) 
Adjusted 
OR (95% 
CI) 
Crude 
OR 
(95% 
CI) 
Adjusted 
OR (95% 
CI) 
Crude 
OR (95% 
CI) 
Adjusted 
OR (95% 
CI) 
215GO .52 (.23-
1.21) 
.79 (.56-1.12) 3.53 
(2.05 – 
6.08)* 
3.69 (1.61-
8.46)* 
1.67 
(1.03-
2.70)* 
2.09 (1.26-
3.47)* 
3.78 
(2.20 – 
6.50)* 
2.01 (1.14-
3.55)* 
13.66 
(5.95-
31.35)* 
14.31 (2.61-
78.27)* 
HC 215GO .34 (.08-
1.47) 
.75 (.50-1.13) 1.25 (.70-
2.24) 
.68 (.23-
1.91) 
.77 (.43-
1.37) 
.38 (.11-
1.34) 
2.16 
(1.22-
3.85)* 
1.28 (.77-
2.13) 
1.97 (.94-
4.16) 
.78 (.50-
1.22) 
Sex (male) 1.01 
(.43-
2.32) 
1.12 (.72-
1.73) 
.54 (.34-
.88)* 
.48 (.34-
.69)* 
1.14 (.71-
1.83) 
1.14 (.69-
1.89) 
.71 (.44-
1.14) 
.63 (.25-
1.54) 
.99 (.56-
1.78) 
1.16 (.39-
3.44) 
Age (yrs) 1.09 
(.99-
1.19) 
1.09 (1.03-
1.17)* 
1.06 
(1.00-
1.12)* 
1.03 (.98-
1.01) 
.97 (.93-
1.03) 
.97 (.92-
1.02) 
1.16 
(1.09-
1.23)* 
1.18 (1.09-
1.28)* 
1.16 
(1.08-
1.24)* 
1.23 (1.09-
1.38)* 
BMI 
Category 
(obese) 
.50 (.19-
1.29) 
.72 (.39-1.29) 1.72 
(1.06-
2.79)* 
1.25 (.81-
1.96) 
1.00 (.62-
1.62) 
.83 (.68-
1.02) 
4.05 
(2.45-
6.68)* 
4.39 (2.16-
8.92)* 
4.92 
(2.60-
9.31)* 
5.4 (1.70-
17.17)* 
White/ 
Other 
.37 (.07-
1.86) 
.08 (.04-.20)* .52 (.17-
1.60) 
.61 (.16-
2.32) 
.56 (.15-
2.11) 
.65 (.43-
.99)* 
2.27 (.61-
8.49) 
4.80 (.99-
23.14) 
.72 (.18-
2.81) 
.88 (.12-
6.24) 
Asian .27 (.08-
.93)* 
.05 (.03-.08)* 1.80 (.63-
5.16) 
1.36 (1.05-
1.78)* 
1.87 (.74-
4.71) 
3.05 (2.44-
3.82)* 
.83 (.33-
2.09) 
1.42 (1.03 -
1.96)* 
.60 (.16-
2.23) 
.05 (.01-
.32)* 
Hispanic .72 (.24-
2.10) 
.35 (.23-.52)* 1.45 (.77-
2.73) 
1.26 (1.12-
1.43)* 
1.87 
(1.04-
3.38)* 
3.27 (2.18-
4.91)* 
2.14 
(1.10-
4.15)* 
2.37 (.76-
7.39) 
1.28 (.57-
2.88) 
2.61 (1.66-
4.11)* 
Note:  Adjusted ORs calculated from GEE models with HC as a cluster effect.  
	  	  	  	  	   
 
 
 
Table 5:  Assessment of laboratory tests. 
 Lab Test   
 Lipids Liver Glucose 
 Controls = 17 (10%) 
215GO=  33 (28%) 
Controls = 6 (3%) 
215GO=  14 (12%) 
Controls = 14 (8%) 
215GO=  26 (22%) 
 Crude 
OR 
(95% 
CI) 
Adjusted 
OR (95% 
CI) 
Crude 
OR 
(95% 
CI) 
Adjusted 
OR (95% 
CI) 
Crude 
OR 
(95% 
CI) 
Adjusted 
OR (95% 
CI) 
215GO 3.75 
(1.97-
7.11)* 
4.75 (2.04-
11.06)* 
3.9   
(1.46 – 
10.51)* 
3.21 (1.01-
10.19)* 
3.36 
(1.67-
6.77)* 
4.75 (1.85-
12.21)* 
HC 
215GO 
1.41 
(.62-
3.18) 
.52 (.19-
1.43) 
5.16 
(.68-
39.38) 
2.54 (.29-
22.27) 
1.23 
(.52-
2.94) 
.45 (.15-
1.36) 
Sex (male) 1.22 
(.66-
2.24) 
1.20 (.63-
2.28) 
1.47 
(.59-
3.67) 
1.35 (.54-
3.42) 
1.35 
(.69-
2.64) 
1.39 (.69-
2.79) 
Age (yrs) 1.08 
(1.01-
1.17)* 
1.07 (.99-
1.16) 
1.02 
(.92-
1.13) 
1.00 (.89-
1.12) 
1.09 
(1.01-
1.19)* 
1.09 (.99-
1.19) 
BMI 
Category 
(obese) 
1.43 
(.75-
2.73) 
.85 (.41-
1.78) 
1.52 
(.57-
4.08) 
.87 (.29-
2.60) 
1.21 
(.60-
2.43) 
.73 (.33-
1.60) 
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Discussion 
 This evaluation of the 215GO! program in the Philadelphia Health Centers aimed 
to determine improvements in both processes of care and outcomes for overweight and 
obese children attributable to the program.  Analyses revealed that children in the 
215GO! program experienced no difference in change of their age and gender specific 
BMI compared to controls (Table 2).  Additionally, patients that visited the 215GO! 
program more frequently failed to show greater improvements in BMI than those that 
visited the program less frequently (Table 3).  However, all measured processes of care 
except for blood pressure recording were significantly more likely in 215GO! patients 
than non-215GO! patients (Table 4 and 5).  These benefits in improved processes of care 
were not observed in control patients at 215GO! HCs compared to control patients at 
non-215GO! HCs.  This result suggests that the 215GO! program improves processes of 
care, but this improvement in processes of care is not translating into improved BMI 
outcomes.   
The failure for improvement in BMI outcome in 215GO! patients corresponds to 
analysis of the LEAP program that utilized a similar structure [24, 25].  LEAP children 
and parent participants were given 4 consultations with a physician over 12 weeks but 
showed no improvement in BMI outcomes [24, 25]. However, findings from this analysis 
of the 215GO! program differ from preliminary analysis of the Healthy Weight Clinics in 
community health centers in Massachusetts [26].  As described previously, that program 
provided children with consultation by a dietitian, monitoring by a clinician, and follow-
up by a case manager.  The analysis of results from this program reveal that 50% of 
patients visiting the clinic at least twice reduced their BMI [26].  It is important to 
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highlight that the results of this analysis are preliminary and fail to have an adequate 
control group or control for confounding or cluster effects.  Nonetheless, the improved 
BMI outcome observed in that program could be attributable to the integration of health 
information technology (HIT) with physician consultation.  HIT is an emerging tool in 
clinical assessment and has been improved outcomes have been attributed to the 
utilization of HIT [26].   HIT may enable physicians to better identify risk factors for 
overweight and obesity and assist them in developing treatment options [35].  A study by 
Bordowitz et al., assessed the documentation of obesity in patient charts pre- and post- 
implementation of electronic medical records (EMR), a type of HIT [35]. That study 
found a 2.3 times increase in documentation of obesity as well as a 1.8 times increase in 
treatment of obesity after the implementation of EMR [35].  EMR helped achieve these 
improvements in by prompting physicians to record specific measurements and 
recommending test and treatment options.  The PDPH operated health centers are in the 
process of transitioning to EMR and this shift may assist physicians in treating childhood 
weight problems.   
Improvements observed in processes of care for 215GO! patients correspond to 
those observed by Young et al., in their Learning Collaborative (LC) [22]. The LC in that 
study worked by providing training and support for physicians.  Physicians in HCs 
participating in the 215GO! program receive training in obesity management and these 
same physicians treat the control patients at the 215GO! HCs.  Therefore, the improved 
processes of care should be observed in those control patients at the 215GO! centers as 
well as in the interventional group, yet those benefits were not observed.   Physicians 
have previously been observed to feel a low self-efficacy in treating childhood 
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overweight and obesity [17-19, 36].  The willingness of children to attend the 215GO! 
clinic may increase physicians’ efficacy in treating the disease and make them more apt 
to provide better quality of care.  The impact of the program on physicians’ attitudes 
toward treating pediatric weight conditions should be examined in future research.   
 The analysis of the laboratory test frequencies in this study is limited and serves 
as an exploratory analysis. The PDPH HCs examined in this study have lab results 
recorded slightly more frequently then observed in other studies, yet lab tests were still 
rarely conducted  [14, 16, 37].  GEE modeling techniques that properly control for 
clustering effects within HCs require large sample sizes, and the relatively low number of 
lab tests prohibited utilizing this technique to assess the adequacy of that outcome 
variable.  Furthermore, the guidelines for appropriate lab tests by the Expert Committee 
and the endocrine expert committee suggest that labs be taken for children over 10 years 
of age depending on BMI percentile and the presence of additional risk factors [11, 12].  
Again, restricting analysis to children greater than 10 years of age in this study sample 
would prohibit the use of GEE modeling as well as greatly reduce the power of the study.  
Finally, PDPH guidelines for appropriate lab tests depend largely on the identification 
and evaluation of family history and complications [38].  This study did not examine the 
identification of family history and complications so fails to possess the ability to 
determine appropriate lab tests based on that definition.  Also, PDPH guidelines do not 
specify the proper frequency of lab tests for children of any age.  Simplification of 
clinical guidelines regarding lab tests may improve physician’s ability to provide 
appropriate treatment.  The transition to EMR in the PDPH clinics may facilitate simpler 
guidelines and increased rates of lab testing.   
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A major strength of this study come from its assessment of both process and 
outcome improvement attributable to an intervention and the high power that was 
attainable from the sample size for most measures.  Previous studies that have examined 
the diagnosis and treatment of childhood overweight and obesity have only looked at the 
current level of these measures, yet this study expands on those results but measuring the 
impact of an intervention [14, 16, 37].  Earlier examinations of the 215GO! program have 
focused particularly on BMI outcomes of children in the program at some of the HCs [32, 
33].  This study builds on those results by including all of the 215GO! HCs and an 
assessment of the processes of care.   Additionally, by including several covariates in the 
model this study allows 215GO! program planners help in assessing target populations 
that may be most likely to reduce their BMI as a result of the program as well as pay 
special attention to those groups that are more likely to increase their BMI.  Identifying 
successful and unsuccessful groups can better help program planners design more 
effective treatment methods.  For example, the analysis of the effect of the number of 
215GO! visits on BMI outcome revealed that older patients with increased follow-up 
time have a greater likelihood of reducing their BMI percentile.    Younger patients and 
those with less follow-up time should be paid special attention to improve their chances 
of reduction in BMI percentile.   
 
Policy Implications 
 Organizational strategies that aim to improve both processes of care and outcomes 
require rigorous analysis to ensure their efficacy.   Organizational changes require 
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coordination and effort between individuals in different disciplines and thus carry indirect 
as well as direct financial costs.  Identifying program strengths and weaknesses 
attributable to these organizational inputs can improve the efficiency of resource 
allocation.  The analysis presented in this paper aims to provide this in depth evaluation 
of the 215GO! organizational program offered in the PDPH clinics.   
An important policy implication that arises from this analysis is that this 
organizational structure alone appears insufficient to reduce the prevalence of overweight 
and obesity in children.  The disproportionate burden of childhood overweight and 
obesity that falls on low-income populations requires further policy intervention that can 
assist clinic based programs in the effort to combat the condition.   Failing to address the 
overweight and obesity epidemic can compromise the productive lives of affected 
individuals [5].  Targeting prevention, early intervention and treatment of overweight and 
obesity would meet social justice goals by providing a more equitable future for 
disadvantaged youths, and the 215GO! program did help identify large children.  
Furthermore, a large portion of the chronic co-morbidities associated with large weight 
status is paid for by public payer programs, such as the State Children’s Health Insurance 
Program (SCHIP) and Medicaid [2].  Thus, inability to design policies and programs that 
successfully treat overweight and obesity will place a greater financial cost to tax payers.  
As suggested by a recent systematic review of randomized controlled trial interventional 
programs, combined physical activity with dietary and behavioral counseling is most 
effective at achieving decreased BMI [27].  Public payer systems could support these 
multi-disciplinary efforts by financially supporting their development.  215GO! offers a 
promising start towards this effort and establishes a simple and relatively low-cost 
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organizational structure that can improve diagnosis and treatment of overweight and 
obesity.   Expanding this program to include a specific physical exercise component may 
help in achieving desired outcomes.  Additionally, supplementation of the 215GO! 
program with school and community based interventions as well as policy alternatives 
will likely increase the chances of successful reduction in BMI outcomes.  
 
Conclusion 
 Childhood overweight and obesity is a growing epidemic in the United States, yet 
there exists a dearth of evidence for effective clinic based programs to both identify and 
treat the condition.   The 215GO! program operates in public health centers that serve one 
of the poorest populations in the country.  The evidence presented here suggests that the 
program fails to reduce BMI.  This observed result underscores the multi-dimensional 
nature of overweight and obesity.  The clinic based treatment program evaluated here is  
insufficient on its own to reduce BMI, but must be complemented with school, 
community, and policy level interventions. The study did find an improvement in 
processes of care attributable to the 215GO! program. Improvements in these processes 
of care are necessary to begin to identify and develop treatment protocols for overweight 
and obesity.   Proper identification and recording of the condition can assist program 
designers in assessing the needs of the community.  Additionally, improved processes of 
care allow physicians to better evaluate their patient and identify risk factors for co-
morbidities.  215GO! is a unique program that provides an organizational structure that 
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influences processes of care and with modification of treatment methods will 
theoretically improve BMI outcomes for participants.  
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